Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People's Republic of China. The company offers Golden Throat Lozenges over-the-counter medicine to relieve symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat Lozenge series products, which includes Dule Lozenges; sugar-free Dule Lozenges; and other sugar free flavors, such as orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn. In addition, the company offers Yinxingye tablets to facilitate blood circulation, remove blood stasis, and dredge energy channels; Golden Throat intestinal series; and Golden Throat Compound Probiotic Lozenges. The company also exports its products to the United States, Canada, Japan, the European Union, Australia, Southeast Asia, Middle East, Mexico, and Africa. Golden Throat Holdings Group Company Limited was founded in 1956 and is headquartered in Liuzhou, the People's Republic of China.
Stock data | 2024 | Change |
---|---|---|
Price | $0.4003330976671615 | N/A |
Market Cap | $295.97M | N/A |
Shares Outstanding | 739.30M | N/A |
Employees | 860.00 | N/A |